TruaceTracing the truth around AIMonday, September 14, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,402 results
Show filters and sorting

AI gains · 778

78
GainHealth· Newly added· Evidence: Moderate (1 source)

XGBoost model predicted PMOS status from detailed body-composition measures with AUC 0.701 in testing, with SHAP highlighting regional fat masses as top predictors.

Using GBD 2021 data, Mendelian randomization, and a clinical cohort, the study quantified global PMOS burden and tested adiposity as a causal determinant, then built machine-learning models from body-composition measures to predict PMOS, with XGBoost reaching AUC 0.701 and SHAP highlighting left-leg and trunk fat mass.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%99

Updated Sep 9, 2026 · TRV-2026-1034

78
GainHealth· Newly added· Evidence: Moderate (1 source)

AI models improve cardiovascular prevention by providing more precise, dynamic and personalized risk stratification than traditional scores and by enabling early detection of subclinical atrial fibrillation, left ventricular dysfunction and coronary disease through AI-enabled ECG and opportunistic imaging.

This peer-reviewed review examines AI, including machine learning and deep learning, for cardiovascular prevention in Italy and globally, where cardiovascular diseases remain the leading cause of mortality and morbidity. It surveys evidence that AI can deliver more precise, dynamic and personalized risk stratification than traditional scores and support early detection of subclinical disease via AI-enabled electrocardiography and opportunistic imaging.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%97

Updated Sep 1, 2026 · TRV-2026-0955

78
GainHealth· Newly added· Evidence: Moderate (1 source)

AI-based support systems could enhance safety and make xenotransplantation more reproducible when combined with gene-edited donors and refined immunosuppression.

On September 1, 2026, a peer-reviewed roadmap in Xenotransplantation outlined how artificial intelligence could be integrated into early clinical xenotransplantation to address organ shortage. It prioritizes digital pathology, machine perfusion monitoring, multimodal graft injury detection, and xenozoonotic infection surveillance, emphasizing clinician-supervised, auditable systems combined with gene-edited donors.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%97

Updated Sep 1, 2026 · TRV-2026-0953

78
GainScience· Stable· Evidence: Moderate (1 source)

Generative AI offers faster and scaled-up foresight that can serve as anticipatory infrastructure for imagining possible futures and foresight solutions.

On 2025-10-14, a peer-reviewed article in Qualitative Research in Psychology proposed a social science futures research agenda centered on artificial intelligence. The author describes a contemporary market for futures knowledge driven by promises of faster, scaled-up AI foresight, and examines Generative AI as an anticipatory infrastructure through which international organizations imagine futures, participants engage with dominant visions, and researchers imagine future methods.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%97

Updated Aug 30, 2026 · TRV-2026-0928

AI problems · 624

78
ProblemMedia & Arts· Stable· Evidence: Moderate (1 source)

The same system showed substantially weaker longer-range referential and narrative continuity, lacking the sustained plotting and thematic organisation observed in Orwell's novel.

Published 2026-08-04, this peer-reviewed comparative case study examines passages from George Orwell's Nineteen Eighty-Four and Ross Goodwin's 2018 sensor-driven LSTM book 1 the Road to assess how generative systems handle literary coherence and creative agency.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%93

Updated Aug 8, 2026 · TRV-2026-0694

78
ProblemHealth· Stable· Evidence: Moderate (1 source)

Medical AI systems built on Western biomedical traditions may inflict ontological harm and diminish trust in patient-clinician relationships by conflicting with relational and Indigenous understandings of health.

Published 6 August 2026 in the South African Medical Journal, this peer-reviewed essay examines data science and medical AI through four lightly fictional but reality-informed case studies from Bamenda to Mthatha to Toronto. It argues that AI tools largely built on Western biomedical traditions may conflict with relational, spiritual and Indigenous understandings of health, manifesting as epistemic friction and diminished trust.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%93

Updated Aug 8, 2026 · TRV-2026-0691

78
ProblemHealth· Stable· Evidence: Moderate (1 source)

High algorithmic accuracy in AI models for ADHD has not yet translated into routine clinical utility without advances in explainability and multimodal fusion.

A bibliometric review of 722 Scopus-indexed papers from 2011 to 2024 tracked how artificial intelligence has been applied to ADHD prediction. Using Python and VOSviewer, the authors found exponential growth peaking in 2023, a concentration of output in the United States and China, and a technological shift from support vector machines to deep learning with EEG becoming the favored data modality.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%92

Updated Aug 3, 2026 · TRV-2026-0630

78
ProblemHealth· Stable· Evidence: Moderate (1 source)

AI-driven modeling for antimicrobial resistance target discovery continues to face persistent challenges around experimental validation and genomic variability, limiting confirmation of predicted functions.

By July 30 2026, a narrative review in Journal of Computer-Aided Molecular Design described the use of structural modeling and artificial intelligence for functional prediction of proteins encoded by multidrug-resistant bacterial genomes. It reported that tools such as AlphaFold and RoseTTAFold have enabled high-accuracy three-dimensional structure prediction, facilitating annotation of hypothetical proteins and identification of conserved domains and catalytic sites.

Impact 30%49
Evidence 25%95
Scale 20%85
Confidence 15%87
Recency 10%91

Updated Jul 31, 2026 · TRV-2026-0599

Recomputed live from the record · Sep 14, 2026, 7:28 AM